{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:26:19Z","timestamp":1788884779844,"version":"build-2803163510"},"reference-count":55,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T00:00:00Z","timestamp":1686787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T00:00:00Z","timestamp":1686787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"name":"Spanish Network for the Research in Infectious Disease"},{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 la Marat\u00f3 de TV3","doi-asserted-by":"publisher","award":["472\/U\/2018"],"award-info":[{"award-number":["472\/U\/2018"]}],"id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"MEC | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["01162"],"award-info":[{"award-number":["01162"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Microbiol Spectr"],"published-print":{"date-parts":[[2023,6,15]]},"abstract":"<jats:p>Antimicrobial resistance (AMR) is one of the greatest public health challenges, accounting for 1.27 million deaths worldwide in 2019. Biofilms, a complex microbial community, directly contribute to increased AMR.<\/jats:p>","DOI":"10.1128\/spectrum.00280-23","type":"journal-article","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T10:05:24Z","timestamp":1681985124000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":34,"title":["<i>In Vitro<\/i>\n                    Antibacterial Activity of Silver Nanoparticles Conjugated with Amikacin and Combined with Hyperthermia against Drug-Resistant and Biofilm-Producing Strains"],"prefix":"10.1128","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4567-9868","authenticated-orcid":true,"given":"Marta","family":"Palau","sequence":"first","affiliation":[{"name":"Antibiotic Resistance Laboratory, Vall d\u2019Hebron Research Institute (VHIR), Infectious Diseases Department, Vall d\u2019Hebron University Hospital, Barcelona, Spain"},{"name":"Spanish Network for Research in Infectious Diseases (REIPI RD19\/0016), Instituto de Salud Carlos III, Madrid, Spain"},{"name":"CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6693-4987","authenticated-orcid":true,"given":"Estela","family":"Mu\u00f1oz","sequence":"additional","affiliation":[{"name":"Antibiotic Resistance Laboratory, Vall d\u2019Hebron Research Institute (VHIR), Infectious Diseases Department, Vall d\u2019Hebron University Hospital, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel F.","family":"Gusta","sequence":"additional","affiliation":[{"name":"Institut Catal\u00e0 de Nanoci\u00e8ncia i Nanotecnologia (ICN2), CSIC, The Barcelona Institute of Science and Technology (BIST), Campus UAB, Bellaterra, Barcelona, Spain"},{"name":"Vall d\u2019Hebron University Hospital, Barcelona, Spain"},{"name":"CIBER en Bioingenier\u00eda, Biomateriales y Nanomedicina, CIBER-BBN, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nieves","family":"Larrosa","sequence":"additional","affiliation":[{"name":"Spanish Network for Research in Infectious Diseases (REIPI RD19\/0016), Instituto de Salud Carlos III, Madrid, Spain"},{"name":"CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain"},{"name":"Microbiology Department, Vall d\u2019Hebron University Hospital, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Gomis","sequence":"additional","affiliation":[{"name":"Antibiotic Resistance Laboratory, Vall d\u2019Hebron Research Institute (VHIR), Infectious Diseases Department, Vall d\u2019Hebron University Hospital, Barcelona, Spain"},{"name":"CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Gilabert","sequence":"additional","affiliation":[{"name":"Tractivus SL, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benito","family":"Almirante","sequence":"additional","affiliation":[{"name":"Antibiotic Resistance Laboratory, Vall d\u2019Hebron Research Institute (VHIR), Infectious Diseases Department, Vall d\u2019Hebron University Hospital, Barcelona, Spain"},{"name":"Spanish Network for Research in Infectious Diseases (REIPI RD19\/0016), Instituto de Salud Carlos III, Madrid, Spain"},{"name":"CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Puntes","sequence":"additional","affiliation":[{"name":"Institut Catal\u00e0 de Nanoci\u00e8ncia i Nanotecnologia (ICN2), CSIC, The Barcelona Institute of Science and Technology (BIST), Campus UAB, Bellaterra, Barcelona, Spain"},{"name":"Vall d\u2019Hebron University Hospital, Barcelona, Spain"},{"name":"CIBER en Bioingenier\u00eda, Biomateriales y Nanomedicina, CIBER-BBN, Madrid, Spain"},{"name":"Instituci\u00f3 Catalana de Recerca i Estudis Avan\u00e7ats (ICREA), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Texid\u00f3","sequence":"additional","affiliation":[{"name":"Grup d\u2019Enginyeria de Materials (GEMAT), Universitat Ram\u00f3n Llull, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9829-3141","authenticated-orcid":true,"given":"Joan","family":"Gavald\u00e0","sequence":"additional","affiliation":[{"name":"Antibiotic Resistance Laboratory, Vall d\u2019Hebron Research Institute (VHIR), Infectious Diseases Department, Vall d\u2019Hebron University Hospital, Barcelona, Spain"},{"name":"Spanish Network for Research in Infectious Diseases (REIPI RD19\/0016), Instituto de Salud Carlos III, Madrid, Spain"},{"name":"CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","volume-title":"Antibiotic resistance threats in the United States, 2019.","author":"CDC","year":"2019","unstructured":"CDC. 2019. Antibiotic resistance threats in the United States, 2019. US Department of Health and Human Services, CDC, Atlanta, GA."},{"key":"e_1_3_2_3_2","first-page":"277","article-title":"The antibiotic resistance crisis. Part 1: causes and threats","volume":"40","author":"Ventola CL","year":"2015","unstructured":"Ventola CL. 2015. The antibiotic resistance crisis. Part 1: causes and threats. P T 40:277\u2013283.","journal-title":"P T"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70318-9"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00474-2"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02724-0"},{"key":"e_1_3_2_7_2","volume-title":"Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of antibiotics.","author":"Tacconelli E","year":"2017","unstructured":"Tacconelli E, Magrini N, World Health Organization. 2017. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of antibiotics. World Health Organization, Geneva, Switzerland."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2475067"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.00539"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1008"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.15.2.167-193.2002"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0809.020063"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-021-02707-w"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro821"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1145"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0912273"},{"key":"e_1_3_2_17_2","first-page":"36","article-title":"Antibiofilm efficacy of silver nanoparticles against biofilm forming multidrug resistant clinical isolates","volume":"6","author":"Ramachandran R","year":"2017","unstructured":"Ramachandran R, Sangeetha D. 2017. Antibiofilm efficacy of silver nanoparticles against biofilm forming multidrug resistant clinical isolates. Pharma Innov J 6:36\u201343.","journal-title":"Pharma Innov J"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20040865"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2015.04.002"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01441"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20020449"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/246012"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.01831"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s42770-020-00406-x"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2013.07.011"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.3109\/02656736.2015.1120889"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.04103-15"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02807-22"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1080\/08927014.2015.1083985"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.4155\/tde.11.72"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S185965"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-18590-6"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1186\/1743-8977-8-36"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.3390\/nano6040074"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1021\/cm500316k"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11051-017-3973-9"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.langmuir.6b02338"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.2217\/nnm.11.19"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tvjl.2015.10.032"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1088\/0957-4484\/16\/9\/082"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1021\/mp900056g"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.06513-11"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1586\/eri.12.25"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11091219"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1039\/c8ra07980c"},{"key":"e_1_3_2_46_2","doi-asserted-by":"crossref","unstructured":"Camargo LDO Fontoura I Veriato TS Raniero L Castilho ML. 26 December 2022. Antibacterial activity if silver nanoparticles functionalized with amikacin applied against multidrug-resistant Acinetobacter baumannii . Am J Infect Control. doi:10.1016\/j.ajic.2022.12.009.","DOI":"10.1016\/j.ajic.2022.12.009"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.3390\/nano7010007"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules20058856"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.bioconjchem.9b00821"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1080\/21691401.2018.1518909"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.0c00114"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05693-3"},{"key":"e_1_3_2_53_2","volume-title":"Breakpoint tables for interpretation of MICs and zone diameters, version 12.0.","author":"European Committee on Antimicrobial Susceptibility Testing","year":"2022","unstructured":"European Committee on Antimicrobial Susceptibility Testing. 2022. Breakpoint tables for interpretation of MICs and zone diameters, version 12.0. EUCAST, Basel, Switzerland. https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/v_12.0_Breakpoint_Tables.pdf."},{"key":"e_1_3_2_54_2","volume-title":"ISO 20776-1. Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices\u2014part 1: broth microdilution reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases.","author":"ISO Technical Committee 212","year":"2019","unstructured":"ISO Technical Committee 212. 2019. ISO 20776-1. Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices\u2014part 1: broth microdilution reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases. ISO, Geneva, Switzerland."},{"key":"e_1_3_2_55_2","first-page":"365","volume-title":"Antibiotics in laboratory medicine","author":"Pillai SK","year":"2005","unstructured":"Pillai SK, Moellering RC, Eliopoulos GM. 2005. Antimicrobial combinations, p 365\u2013440. In Lorian V (ed), Antibiotics in laboratory medicine, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.","edition":"5"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2008.192"}],"container-title":["Microbiology Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.00280-23","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.00280-23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T09:21:52Z","timestamp":1686820912000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/spectrum.00280-23"}},"subtitle":[],"editor":[{"given":"Krisztina M.","family":"Papp-Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,6,15]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6,15]]}},"alternative-id":["10.1128\/spectrum.00280-23"],"URL":"https:\/\/doi.org\/10.1128\/spectrum.00280-23","relation":{},"ISSN":["2165-0497"],"issn-type":[{"value":"2165-0497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,15]]},"assertion":[{"value":"2023-01-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-31","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00280-23"}}